Market Cap: $58.86B
Market Cap: $58.86B
Open
$157.52
Prev. Close
$215.42
High
$158.01
Low
$154.33
Operating globally, Becton, Dickinson and Company (BD) is a prominent enterprise focused on the development, manufacturing, and distribution of a broad spectrum of medical technology. This includes essential medical supplies, sophisticated devices, advanced laboratory equipment, and critical diagnostic products.
Becton, Dickinson and Company trades on the New York Stock Exchange under the ticker BDX, priced in USD.
Becton, Dickinson and Company has a market capitalisation of $58.86B, based on its latest share price.
BDX trades at 58.78 times its trailing 12-month earnings.
Over the past 52 weeks BDX has traded between $140.11 and $220.36.
Yes. Becton, Dickinson and Company's dividend yields 2.04% at the current share price, paying out 187% of its earnings.
Profitable, with a net margin of 4.5% over the last 12 months.
The analyst consensus rating for BDX is Buy. Analysts' average 12-month price target of $185.17 implies 14% downside.
Thomas E. Polen Jr. is the CEO of Becton, Dickinson and Company, which is headquartered in Franklin Lakes.
Generated automatically from reported financial data. General information only, not financial advice.

Becton, Dickinson and Company ( BDX ) has recently showcased its commitment to innovation and growth in the medical technology sector through a series of strategic initiatives and partnerships. As the…

Becton Dickinson & Company (Ticker: BDX) announces an important milestone with the award of an Innovative Technology contract for its BD CentroVena One Insertion System from Vizient. This contract hig…

Becton Dickinson & Company (Ticker: BDX) has recently received significant recognition in the healthcare industry with its BD CentroVena One Insertion System being awarded an Innovative Technology con…

Becton Dickinson & Company (Ticker: BDX) continues to strengthen its position in the medical technology arena, having recently received an Innovative Technology contract from Vizient for its BD® Centr…